Skip to main content
2026 CRT Conference Main banner

CRT 2026

Coronary

Session:: ACS and AMI Management

Which IV Antiplatelet Agent is Optimal for Acute Treatment During High-Risk PCI? Short Infusion With GPIs or Cangrelor?

Sunday, March 8, 2026
3:18 PM - 3:26 PM EST
Location: Lincoln

    Speaker(s)

  • Paul A. Gurbel, MD, FSCAI

    Director
    Sinai Center for Thrombosis Research and Drug Development
    Baltimore, Maryland, United States

    Disclosure information not submitted.